IAIM
NAGE

International Assets Investment Management’s Niagen Bioscience NAGE Stock Holding History

International Assets Investment Management’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-20,000
Closed -$28.6K – 838
2023
Q4 		$28.6K Hold
20,000
– – ﹤0.01% 717
2023
Q3 		$29K Hold
20,000
– – ﹤0.01% 602
2023
Q2 		$31.4K Hold
20,000
– – ﹤0.01% 603
2023
Q1 		$30.6K Hold
20,000
– – ﹤0.01% 748
2022
Q4 		$33.6K Buy
+20,000
New +$31.7K ﹤0.01% 768

Other funds holding NAGE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tieton Capital Management Yakima, Washington $299M AUM 54.55% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
GI
GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

International Assets Investment Management's NAGE Position: Q1 2024 in Review

International Assets Investment Management sold out of Niagen Bioscience (NAGE) in Q1 2024, closing a stake of 20,000 shares — an estimated $28.6K sold.

International Assets Investment Management first reported a position in NAGE in Q4 2022 and held it in 5 quarters. The position peaked at $33.6K in Q4 2022. 67 funds tracked by Wall St. Rank hold NAGE as of Q1 2024.

  • International Assets Investment Management reported no remaining Niagen Bioscience position as of Q1 2024 after selling out during the quarter.
  • International Assets Investment Management sold 20,000 Niagen Bioscience shares in Q1 2024, an estimated $28.6K.
  • International Assets Investment Management first reported a position in Niagen Bioscience in Q4 2022 and held it in 5 quarters.
  • International Assets Investment Management's Niagen Bioscience position peaked at $33.6K in Q4 2022.
  • 67 funds tracked by Wall St. Rank held Niagen Bioscience as of Q1 2024.

Based on International Assets Investment Management's 13F filing for Q1 2024, filed 11 Apr 2024.